Background. Thromboelastography (TEG) unlike conventional coagulation assays evaluates the dynamic interaction of clotting factors and platelets indicating an overall clot quality. Literature assessing the efficacy of TEG in identifying trauma associated bleeding is lacking. Aim. To compare TEG with conventional plasma based coagulation tests and assess whether TEG can serve as a screening test or replace the conventional routine test. Materials. Retrospective data was collected for 150 severe trauma patients. Patients with known evidence of severe comorbidities, which may influence the outcome, were excluded. Detailed evaluation of the patient’s clinical and laboratory records was conducted. Diagnostic characteristics such as sensitivity, specificity, and accuracy were calculated. Results. Fifty-one patients were defined as coagulopathic by the conventional coagulation test, 30 by the laboratory established range for TEG indices and 105 by manufactures range. Specificity and sensitivity for the laboratory established range for TEG were 29.4% and 84.8%; for manufactures range sensitivity was 74.5%, specificity was 32.3%. Conclusion. We observed that conventional coagulation assays are the most sensitive tests for diagnosis of coagulopathy due to trauma. However in emergency trauma situations, where immediate corrective measures need to be taken, coagulation parameters and conventional coagulation tests may cause delay. TEG can give highly specific results depicting the underlying coagulopathy. 1. Introduction High frequency of established coagulopathy (30%) in multiply injured trauma patients has been reported, which accounts for up to 40% of all trauma-related deaths [1]. The standard laboratory screening tests of coagulation are the prothrombin time (PT) and activated partial thromboplastin time (aPTT), which can be affected adversely by poor sampling technique; they vary in their complexity, turnaround time for clinical decision-making, and result reproducibility and have a need for special preparation or personnel [2]. Thromboelastography (TEG) is a noninvasive diagnostic assay to evaluate the viscoelastic properties during blood clot formation and clot lysis, yielding a graphical and numerical output relating to the cumulative effects of various plasma and cellular elements of all phases of the coagulation and fibrinolysis [3]. Numerous studies have reported the utilization of TEG as a monitoring device for hemostasis and transfusion management in various clinical settings, for example, cardiac surgery [4], liver transplantation [5], identification
References
[1]
M. Maegele, R. Lefering, N. Yucel et al., “Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients,” Injury, vol. 38, no. 3, pp. 298–304, 2007.
[2]
A. N. Curry and J. M. Pierce, “Conventional and near-patient tests of coagulation,” Continuing Education in Anaesthesia, Critical Care and Pain, vol. 7, no. 2, pp. 45–50, 2007.
[3]
A. O. Spiel, F. B. Mayr, C. Firbas, P. Quehenberger, and B. Jilma, “Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans,” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 411–416, 2006.
[4]
L. Shore-Lesserson, H. E. Manspeizer, M. DePerio, S. Francis, F. Vela-Cantos, and M. A. Ergin, “Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery,” Anesthesia and Analgesia, vol. 88, no. 2, pp. 312–319, 1999.
[5]
E. Cerutti, C. Stratta, R. Romagnoli et al., “Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation,” Liver Transplantation, vol. 10, no. 2, pp. 289–294, 2004.
[6]
P. Sharma and R. Saxena, “A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state,” American Journal of Clinical Pathology, vol. 134, no. 1, pp. 97–102, 2010.
[7]
J. L. Kashuk, E. E. Moore, A. Sabel et al., “Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients,” Surgery, vol. 146, no. 4, pp. 764–774, 2009.
[8]
D. Royston and S. von Kier, “Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass,” British Journal of Anaesthesia, vol. 86, no. 4, pp. 575–578, 2001.
[9]
L. M. Trapani, “Thromboelastography: current applications, future directions,” Open Journal of Anesthesiology, vol. 3, pp. 23–27, 2013.
[10]
S. R. Ostrowski, A. M. S？rensen, C. F. Larsen, and P. I. Johansson, “Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, vol. 19, p. 64, 2011.
[11]
W. Z. Martini, D. S. Cortez, M. A. Dubick, M. S. Park, and J. B. Holcomb, “Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs,” The Journal of Trauma, vol. 65, no. 3, pp. 535–543, 2008.
[12]
S. M. Goobie, S. G. Soriano, D. Zurakowski, F. X. McGowan, and M. A. Rockoff, “Hemostatic changes in pediatric neurosurgical patients as evaluated by thrombelastograph？,” Anesthesia and Analgesia, vol. 93, no. 4, pp. 887–892, 2001.
[13]
K. Thorsen, K. G. Ringdal, K. Strand, E. S？reide, J. Hagemo, and K. S？reide, “Clinical and cellular effects of hypothermia, acidosis and coagulopathy in major injury,” British Journal of Surgery, vol. 98, no. 7, pp. 894–907, 2011.
[14]
T. Ruttmann, “Coagulation for the clinician,” South African Journal of Surgery, vol. 44, no. 1, pp. 22–30, 2006.
[15]
Y. G. Kang, D. J. Martin, and J. Marquez, “Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation,” Anesthesia and Analgesia, vol. 64, no. 9, pp. 888–896, 1985.
[16]
W. S. Howland, O. Schweizer, and P. Gould, “A comparison of intraoperative measurements of coagulation,” Anesthesia and Analgesia, vol. 53, no. 5, pp. 657–663, 1974.
[17]
C. M. Samama, “Thromboelastography: the next step,” Anesthesia and Analgesia, vol. 92, no. 3, pp. 563–564, 2001.
[18]
S. Scarpelini, S. G. Rhind, B. Nascimento et al., “Normal range values for thromboelastography in healthy adult volunteers,” Brazilian Journal of Medical and Biological Research, vol. 42, no. 12, pp. 1210–1217, 2009.
[19]
C. W. Whitten and P. E. Greilich, “Thromboelastography: past, present, and future,” Anesthesiology, vol. 92, no. 5, pp. 1223–1225, 2000.
[20]
S. Vig, A. Chitolie, D. H. Bevan, A. Halliday, and J. Dormandy, “Thromboelastography: a reliable test?” Blood Coagulation and Fibrinolysis, vol. 12, no. 7, pp. 555–561, 2001.
[21]
J. H. Essell, T. J. Martin, J. Salinas, J. M. Thompson, and V. C. Smith, “Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 7, no. 4, pp. 410–415, 1993.
[22]
A. K. Akobeng, “Understanding diagnostic tests 1: sensitivity, specificity and predictive values,” Acta Paediatrica, vol. 96, no. 3, pp. 338–341, 2007.
[23]
W. Zhu, N. Zeng, and N. Wang, “Sensitivity, specificity, accuracy, associated confidence interval and roc analysis with practical SAS implementations,” in Proceedings of the NESUG Health Care and Life Sciences, Baltimore, Md, USA, 2010.
